.png)
The Global Wound Healing Crisis
Chronic wounds affect over 40 million patients worldwide, costing healthcare systems billions annually. Traditional approaches β antibiotics, surgical debridement, and advanced dressings β often fail to achieve closure in long-standing wounds.
How VIPP Addresses Chronic Wounds
CellSonic VIPP tackles the root causes of failed wound healing simultaneously:
- Eliminates biofilm and infection β The 25,000-volt electrical discharge creates conditions lethal to bacteria, including antibiotic-resistant strains like MRSA
- Stimulates angiogenesis β New blood vessel formation restores oxygen and nutrient supply to the wound bed
- Activates growth factors β VEGF, PDGF, and TGF-Ξ² release is triggered by the mechanical stimulus
- Restores cell voltage β Diseased cells at -10mV are restored to healthy -75mV
Documented Results
In documented cases, CellSonic VIPP has achieved wound closure in patients whose wounds had persisted for months or even decades. One remarkable case in Pakistan saw a 50-year-old wound achieve complete closure after just 6 treatment sessions.
A series of 3 wound patients documented by CellSonic practitioners showed consistent improvement across different wound types, with complete or near-complete closure in all cases.
Why Biophysics Succeeds Where Biochemistry Fails
Traditional wound care relies on biochemistry β drugs, antibiotics, and topical agents. When these fail, the wound becomes "chronic." VIPP therapy introduces biophysics as a third approach: using physical forces (pressure, light, and electrical fields) to trigger innate healing mechanisms.
This paradigm shift β from chemical to physical medicine β is what makes CellSonic's approach fundamentally different and, in many cases, more effective.
Read our case studies for documented treatment outcomes.
